Mary Garcia, APRN
Family · Wichita, KSNPI 1982221073
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $15,185 of the $24,217 with a category attached, or 62.7%. 26 manufacturers reported payments, led by Ferring Pharmaceuticals Inc. at 53.5% of the total. Reporting peaked in 2024 at $10,509 and has fallen 59.6% since, to $4,245 in 2025. Among family clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 296 payments — averaging $81.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals Inc.$13K
- AbbVie$7K
- Insmed, Inc.$763
- Gilead$711
- Takeda Pharmaceuticals U.S.A., Inc.$444
- Merck$285
- plus $2K from 20 others
What the payments were for
- Consulting fees$2001%
- Speaking & faculty fees$15,18563%
- Travel & lodging$2,1379%
- Food & beverage$6,09025%
- Education$6063%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 62 | $12,958 |
| AbbVie | 61 | $7,308 |
| Insmed, Inc. | 41 | $763 |
| Gilead | 18 | $711 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $444 |
| Merck | 17 | $285 |
| Melinta Therapeutics, LLC | 16 | $244 |
| Aimmune Therapeutics, Inc. | 9 | $191 |
| Hospira, Inc. | 10 | $165 |
| Biowound Solutions, Inc. | 2 | $139 |
| Viiv Healthcare Company | 2 | $138 |
| Octapharma USA, Inc. | 6 | $115 |
| Grifols USA, LLC | 5 | $113 |
| Mayne Pharma Commercial LLC | 4 | $91 |
| CSL Behring | 5 | $87 |
| AstraZeneca | 4 | $74 |
| Pfizer | 3 | $65 |
| Paratek Pharmaceuticals, Inc. | 4 | $60 |
| Tersera Therapeutics LLC | 2 | $49 |
| Invivyd Inc | 2 | $47 |
| La Jolla Pharmaceutical Company | 2 | $44 |
| Shionogi Inc | 2 | $42 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $29 |
| Nestle Healthcare Nutrition Inc. | 1 | $22 |
| Dynavax Technologies Corporation | 1 | $18 |
| Convatec Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$24,217 in reported general payments places this provider in the 95th percentile of 1,579 family providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methenamine Hippurate | 239 | $14,632 |
| Itraconazole | 15 | $7,930 |
| Rifabutin | 19 | $7,541 |
| Rifampin | 35 | $3,054 |
| Ethambutol Hcl | 45 | $2,840 |
| Cephalexin | 138 | $2,598 |
| Vancomycin Hcl | 11 | $1,764 |
| Azithromycin | 63 | $1,730 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 68 | $1,290 |
| Cefdinir | 33 | $1,261 |
| Clindamycin Hcl | 29 | $1,220 |
| Ciprofloxacin Hcl | 62 | $693 |
| Doxycycline Hyclate | 37 | $674 |
| Minocycline Hcl | 22 | $533 |
| Fluconazole | 25 | $357 |
Paid to pharmacies, not to this prescriber.
Other family in Wichita
- Kayla del RioWichita$147K
- Kelli RiceWichita$114K
- Mary GonzalesWichita$87K
- Jennifer NeelWichita$15K
- Amanda AstWichita$9K
- Jennifer MartinWichita$8K
- Lauren CoteWichita$7K
- Mimi TranWichita$6K
- Kara NabboutWichita$6K
- Zohra HussainiKansas City$329K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.